As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; ...

On June 18, 2026, Judge Denise J. Casper of the United States District Court for the District of Massachusetts dismissed a putative class ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the ...

Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Medical innovation is exciting. It’s thrilling to think a new therapy, device or product can improve the quality of or save ...

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with ...

Hong Kong-listed AI-driven drug delivery innovation company Metis TechBio Co Ltd said on Tuesday it had granted Boulevard Bio ...

Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic Therapeutics ...

Cytonics Corporation, a clinical-stage biopharmaceutical company developing novel Alpha-2-Macroglobulin (A2M)-based therapeutics for osteoarthritis, today announced completion of the Clinical Study ...